United States · Investor

Johnson & Johnson Development Corporation (JJDC)

Last cheque observed Nov 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firmNow at jnjinnovation.com

BuyoutGrowthSeedBiotechConsumerConsumer Products

Cheques on record
0%of best year0cheques in 12 months, 117 on record
Since the last cheque4367days00hrs00min00sec
Median round$25MRounds led0 of 117Sole investor5 roundsExits12 from the portfolioMostly inUnited States, 67%
Pitch Johnson & Johnson Development Corporation (JJDC)

Johnson & Johnson Development Corporation (JJDC) highlights

  1. 01

    117 rounds on record

  2. 02

    Mostly Series B and Series C: 55% of its rounds

  3. 03

    Sole investor in 5 rounds, median $9.0M

  4. 04

    12 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
BuyoutGrowthSeedSeries A
Sectors
BiotechConsumerConsumer Products
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first117 appearances

  1. 2014

    11 rounds

  2. Nov
    La LumiereSeries B · US$20MWith 1 other
  3. Sept
    InivataSeries A · GB$6.5MWith 2 others
  4. Sept
    BiocartisSeries F · CH$85MWith 2 others
  5. Jun
    Navitor PharmaceuticalsSeries A · US$24MWith 3 others
  6. Jun
    Aduro BioTechSeries C · US$55MWith 1 other
  7. May
    Rodin TherapeuticsSeries A · US$13MWith 1 other
  8. May
    Inspire Medical SystemsSeries E · US$40MWith 8 others
  9. Apr
    Atlas GeneticsSeries B · GB$28MWith 5 others
  10. Feb
    Thesan PharmaceuticalsSeries B$49MWith 6 others
  11. Jan
    PowerVisionSeries D · US$20MWith 6 others
  12. Jan
    TopiVertVenture · GB$6.8MWith 3 others
  13. 2013

    14 rounds

  14. Nov
    PulmocideSeries A · GB · finsmes.com$28MWith 4 others
  15. Nov
    BiocartisSeries E · CH · finsmes.com$39MWith 5 others
  16. Oct
    MerusSeries B · NL · finsmes.com$40MWith 4 others
  17. Jul
    ReVision OpticsSeries E · US · finsmes.com$55MWith 5 others
  18. Jul
    CVRxSeries F · US · finsmes.com$30MWith 4 others
  19. Jul
    ViaCyteSeries C · US · pehub.com$11MWith 1 other
  20. Jul
    NeuroPaceVenture · US · bizjournals.com$18MWith 4 others
  21. Jun
    Rodin TherapeuticsSeed · US · pevc.dowjones.comUndisclosedWith 1 other
  22. Jun
    Protagonist TherapeuticsSeries B · AU · protagonist-inc.com$14MWith 2 others
  23. Apr
    ReVision OpticsSeries E · US · sec.gov$15MWith 4 others
  24. Apr
    Aquinox PharmaceuticalsSeries C · CA · finance.yahoo.com$18MWith 4 others
  25. Apr
    Catalyst BiosciencesVenture · US$5.1MWith 5 others
  26. Mar
    NevroSeries C · US · finsmes.com$48MWith 8 others
  27. Feb
    OptiScan BiomedicalGrowth · US · venturedeal.com$31MWith 3 others
  28. 2012

    11 rounds

  29. Dec
    BiocartisSeries D · CH$45MWith 4 others
  30. Oct
    Genocea BiosciencesSeries C · US · masshightech.com$30MWith 9 others
  31. Sept
    Catalyst BiosciencesVenture · US · sec.gov$13MWith 4 others
  32. Jun
    Astute MedicalSeries C · US · finsmes.com$40MWith 5 others
  33. Jun
    PhaseBio PharmaceuticalsSeries B · US · pevc.dowjones.com$23MWith 4 others
  34. May
    MitralignSeries D · US · finsmes.com$35MWith 5 others
  35. Apr
    Direct Flow MedicalVenture · US$284KWith 8 others
  36. Feb
    CelladonVenture · US · finsmes.com$43MWith 5 others
  37. Jan
    iScience InterventionalVenture · US · researchviews.com$2.8MWith 5 others
  38. Jan
    PowerVisionSeries C · US · finsmes.com$13MSole investor
  39. Jan
    PronotaSeries C · BE · pronota.com$4.8MWith 6 others
  40. 2011

    8 rounds

  41. Nov
    BiocartisSeries C · CH · finsmes.com$96MWith 2 others
  42. Jul
    NevroVenture · US · finsmes.com$58MWith 6 others
  43. Jul
    Atlas GeneticsSeries B · GB · atlasgenetics.com$27MWith 4 others
  44. Jun
    Spinal ModulationSeries D · US · businesswire.com$30MWith 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed12 in all

AccumetricsBought by ITCUndisclosedAug 2013
SyntaxinBought by Ipsen$206MJul 2013
InfoMedicsBought by Physicians InteractiveUndisclosedDec 2012
Acuity PharmaceuticalsBought by OPKO HealthUndisclosedJun 2011
TengionListedUndisclosedApr 2010
InSound MedicalBought by Sonova HoldingUndisclosedJan 2010
ReplidyneBought by Cardiovascular SystemsUndisclosedFeb 2009
Critical Therapeutics,Inc.Bought by Cornerstone TherapeuticsUndisclosedMay 2008
Vascular ArchitectsBought by LeMaitre VascularUndisclosedSept 2007
BioRexisBought by PfizerUndisclosedFeb 2007
Cyrano SciencesBought by Smiths DetectionUndisclosedMar 2004
CardioMEMSBought by St. Jude MedicalUndisclosedNov 2003

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Johnson & Johnson Development Corporation (JJDC). A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Johnson & Johnson Development Corporation (JJDC)

What does Johnson & Johnson Development Corporation (JJDC) invest in?

Johnson & Johnson Development Corporation (JJDC) invests most often at Series B and Series C (55% of the rounds on record), in sectors such as Biotech, Consumer and Consumer Products.

How active is Johnson & Johnson Development Corporation (JJDC)?

117 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2014.

How big are Johnson & Johnson Development Corporation (JJDC)'s cheques?

The median round it joins is $25M.

Does Johnson & Johnson Development Corporation (JJDC) lead rounds?

Rarely, if at all: none of its 117 investments on record names it as the lead.

Where does Johnson & Johnson Development Corporation (JJDC) invest?

Most of the companies it backs are in the United States (67%), the United Kingdom (13%) and Switzerland (10%).

Is Johnson & Johnson Development Corporation (JJDC) investing now?

No investments in the last 12 months; the latest was in Nov 2014.

Who does Johnson & Johnson Development Corporation (JJDC) invest alongside?

Most often Domain Associates (11 rounds together), New Enterprise Associates (9 rounds together) and Quaker Partners (9 rounds together).

What kind of investor is Johnson & Johnson Development Corporation (JJDC)?

Johnson & Johnson Development Corporation (JJDC) is a VC firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it